03/10/2022
Isoray to Participate in the Oppenheimer
32nd Annual Healthcare Conference RICHLAND, WASHINGTON – March 10, ...
03/02/2022
Study Finds Excellent Outcomes for Intermediate Risk
Prostate Cancer Patients Treated with Isoray’s ...
02/08/2022
Revenue Increased 19% Year-Over-Year
Prostate Brachytherapy Revenue Increased 13% Year-Over-Year RICHLAND, ...
01/26/2022
Conference Call is Tuesday, February 8, 2022 at 4:30 p.m. ET/1:30 p.m. PT
RICHLAND, WASHINGTON – January 26, 2022
11/10/2021
Prostate Revenue Increased Year-Over-Year for Second Consecutive Quarter Non-Prostate Brachytherapy Revenue ...
10/29/2021
Conference Call is Wednesday, November 10, 2021 at 4:30 p.m. ET/1:30 p.m. PT
RICHLAND, WASHINGTON –October 29, ...
09/28/2021
RICHLAND, WASHINGTON – September 28, 2021 – The American Brachytherapy Society (ABS) has recognized Isoray’s ...
09/21/2021
Conference Call Rescheduled for Wednesday,
September 22 at 10:00 a.m. ET/7:00 a.m. PT
RICHLAND, ...
09/21/2021
Record Full Year Revenue
Fiscal Fourth Quarter Revenue Increased 19% Year-Over-Year
RICHLAND, WASHINGTON – ...
09/09/2021
Conference Call is Tuesday, September 21 at 4:30 p.m. ET/1:30 p.m. PT
RICHLAND, WASHINGTON – September 9, 2021 – ...
05/13/2021
Revenue Increased 10% Sequentially
Record Non-Prostate Brachytherapy Revenue Increased 20% ...
04/29/2021
Conference Call is Thursday, May 13 at 4:30 p.m. ET/1:30 p.m. PT
RICHLAND, WASHINGTON – April 29, 2021 – Isoray, ...
Media & Public Relations Contact
If you have questions or need help, please contact Sharon Schultz:
Sharon Schultz
Public and Media Relations